No abstract available
MeSH terms
-
Antineoplastic Agents / therapeutic use
-
Clinical Trials as Topic
-
Cohort Studies
-
Combined Modality Therapy
-
Drug Resistance, Neoplasm
-
Graft vs Tumor Effect
-
Humans
-
Immunosuppressive Agents / administration & dosage
-
Immunosuppressive Agents / therapeutic use
-
Lymphocyte Depletion
-
Lymphocyte Transfusion
-
Lymphoma, Follicular / drug therapy
-
Lymphoma, Follicular / pathology
-
Lymphoma, Follicular / surgery*
-
Neoplasms, Radiation-Induced / etiology
-
Neoplasms, Second Primary / etiology
-
Peripheral Blood Stem Cell Transplantation*
-
Survival Rate
-
T-Lymphocytes
-
Transplantation Conditioning / adverse effects
-
Transplantation Conditioning / methods*
-
Transplantation, Autologous
-
Transplantation, Homologous*
-
Whole-Body Irradiation / adverse effects
Substances
-
Antineoplastic Agents
-
Immunosuppressive Agents